UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

British journal of cancer, 2013-09, Vol.109 (6), p.1693-1698

2013

Volltextzugriff (PDF)

359 Long-term Recovery From Hair Loss in Patients with Breast Cancer Who Have Received Chemotherapy

European journal of cancer (1990), 2012-03, Vol.48, p.S148-S148

2012

Volltextzugriff (PDF)

237. Risk factors for loco-regional recurrence after nipple-sparing mastectomy for breast cancer

European journal of surgical oncology, 2012-09, Vol.38 (9), p.810-810

2012

Volltextzugriff (PDF)

5161 POSTER Decision Impact and Economic Evaluation of the 21-gene Recurrence Score (RS) Assay for Physicians and Patients in Japan

European journal of cancer (1990), 2011, Vol.47, p.S378-S378

2011

Volltextzugriff (PDF)

P284 Baseline assessment of patient-reported outcomes (PROs) for breast cancer patients after 5-years of endocrine treatment in a randomized clinical trial: NSAS-BC 05

Breast (Edinburgh), 2011-03, Vol.20, p.S68-S68

2011

Volltextzugriff (PDF)

P209 Evaluating conventional pathological factors against the standardized 21-gene signature for hormone receptor positive breast cancer patients

Breast (Edinburgh), 2011, Vol.20, p.S46-S47

2011

Volltextzugriff (PDF)

P110 Clinical feature of breast ductal carcinoma in situ arising in sclerosing adenosis

Breast (Edinburgh), 2011, Vol.20, p.S19-S19

2011

Volltextzugriff (PDF)

Abstract P2-08-28: Association between rim enhancement on magnetic resonance imaging and response of chemo therapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-28

2016

Volltextzugriff (PDF)

Abstract GS3-04: A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-04-GS3-04

2019

Volltextzugriff (PDF)

Pregnancy-Associated Breast Cancer: Chemotherapy During Pregnancy

Annals of oncology, 2012-09, Vol.23, p.ix133

2012

Volltextzugriff (PDF)

Abstract P3-14-10: Conversion to node-negative after neoadjuvant chemotherapy is a surrogate prognostic marker in patients with hormone receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-14-10

2013

Volltextzugriff (PDF)

Abstract P6-07-38: The Value of Progesterone Receptor in Predicting the Recurrence Score for Hormone-Receptor–Positive Invasive Breast Cancer Patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-38

2012

Volltextzugriff (PDF)

199P - Change in HER2 Status After Neoadjuvant Chemotherapy and the Survival Impact

Annals of oncology, 2012-09, Vol.23, p.ix82-ix82

2012

Volltextzugriff (PDF)

Is There any Difference in Clinicopathological Factors and Prognosis of the Young Breast Cancer?

Annals of oncology, 2012-09, Vol.23, p.ix100-ix101

2012

Volltextzugriff (PDF)

Change in HER2 Status After Neoadjuvant Chemotherapy and the Survival Impact

Annals of oncology, 2012-09, Vol.23, p.ix82

2012

Volltextzugriff (PDF)

Abstract P1-01-12: The Performance of the One Step Nucleic acid Amplification (OSNA) Assay in Breast Cancer Patients with Receiving Preoperative Systemic Therapy

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P1-P1-01-12

2012

Volltextzugriff (PDF)

Abstract P2-02-11: Accuracy of MRI and ultrasonography in predicting pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-02-11

2013

Volltextzugriff (PDF)

Abstract P6-07-23: Proportion of invasive micropapillary carcinoma lesion and primary breast cancer prognosis

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-23

2012

Volltextzugriff (PDF)

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose

Cancer, 1998-06, Vol.82 (11), p.2227-2234

1998

Volltextzugriff (PDF)

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

Clinical imaging, 2006, Vol.30 (1), p.71-71

2006

Volltextzugriff (PDF)

Abstract P5-15-06: Societal economics of the 21-gene Recurrence Score® in estrogen-receptor-positive early-stage breast cancer in Japan

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-15-06

2012

Volltextzugriff (PDF)

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

European radiology, 2005-07, Vol.15 (7), p.1353-1360

2005

Volltextzugriff (PDF)

Abstract P2-02-06: Efficacy and Cost Benefit of Preoperative MRI in the Diagnostic Procedure for Operable Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-02-06

2010

Volltextzugriff (PDF)

Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer (MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10592-10592

2011

Volltextzugriff (PDF)

Dynamic helical CT-guided needle localization of non-palpable and mammographically occult breast lesions : Case reports

Acta radiologica (1987), 2001-07, Vol.42 (4), p.383-385

2001

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(53)

Sprache

Englisch
(49)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Female
(18)
Humans
(18)
Life Sciences & Biomedicine
(13)
Middle Aged
(13)
Science & Technology
(13)
Adult
(11)
Aged
(11)
Breast Neoplasms - Pathology
(8)
Male
(7)
Biological And Medical Sciences
(6)
Hematology, Oncology And Palliative Medicine
(6)
Medical Sciences
(6)
Prognosis
(6)
Aged, 80 And Over
(5)
Breast Cancer
(5)
Dentistry
(5)
Pathology
(5)
Biopsy, Needle
(4)
Breast Neoplasms - Diagnostic Imaging
(4)
Breast Neoplasms - Surgery
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

359 Long-term Recovery From Hair Loss in Patients with Breast Cancer Who Have Received Chemotherapy

237. Risk factors for loco-regional recurrence after nipple-sparing mastectomy for breast cancer

5161 POSTER Decision Impact and Economic Evaluation of the 21-gene Recurrence Score (RS) Assay for Physicians and Patients in Japan

P284 Baseline assessment of patient-reported outcomes (PROs) for breast cancer patients after 5-years of endocrine treatment in a randomized clinical trial: NSAS-BC 05

P209 Evaluating conventional pathological factors against the standardized 21-gene signature for hormone receptor positive breast cancer patients

P110 Clinical feature of breast ductal carcinoma in situ arising in sclerosing adenosis

Abstract P2-08-28: Association between rim enhancement on magnetic resonance imaging and response of chemo therapy

Abstract GS3-04: A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

Pregnancy-Associated Breast Cancer: Chemotherapy During Pregnancy

Abstract P3-14-10: Conversion to node-negative after neoadjuvant chemotherapy is a surrogate prognostic marker in patients with hormone receptor-positive breast cancer

Abstract P6-07-38: The Value of Progesterone Receptor in Predicting the Recurrence Score for Hormone-Receptor–Positive Invasive Breast Cancer Patients

199P - Change in HER2 Status After Neoadjuvant Chemotherapy and the Survival Impact

Is There any Difference in Clinicopathological Factors and Prognosis of the Young Breast Cancer?

Change in HER2 Status After Neoadjuvant Chemotherapy and the Survival Impact

Abstract P1-01-12: The Performance of the One Step Nucleic acid Amplification (OSNA) Assay in Breast Cancer Patients with Receiving Preoperative Systemic Therapy

Abstract P2-02-11: Accuracy of MRI and ultrasonography in predicting pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy

Abstract P6-07-23: Proportion of invasive micropapillary carcinoma lesion and primary breast cancer prognosis

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

Abstract P5-15-06: Societal economics of the 21-gene Recurrence Score® in estrogen-receptor-positive early-stage breast cancer in Japan

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

Abstract P2-02-06: Efficacy and Cost Benefit of Preoperative MRI in the Diagnostic Procedure for Operable Breast Cancer

Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer (MBC)

Dynamic helical CT-guided needle localization of non-palpable and mammographically occult breast lesions : Case reports

Suchergebnisse filtern